IDT continues to support International Genetically Engineered Machine competition

NewsGuard 100/100 Score

Integrated DNA Technologies (IDT), the global leader in nucleic acid synthesis, announces its 2016 Platinum Level sponsorship of the International Genetically Engineered Machine (iGEM) competition. The iGEM Foundation conducts a yearly international competition for students interested in synthetic biology. Last year, more than 280 teams from 39 countries participated in the competition. IDT also will provide each registered team with up to 20KB of its market leading gBlocks® Gene Fragments synthetic DNA products—for a total value of almost US$1M.

“We are very proud to continue our support of iGEM teams that enable future scientists to contribute to the advancement of synthetic biology,” said Joseph Walder, President and Chief Executive Officer of IDT. “Every year, they produce amazing research and contribute to the general public’s understanding of how recombinant organisms can improve our future when used responsibly.”

Randy Rettberg, Founder, President, and Chief Executive Officer of the iGEM Foundation said:

With this offer, iGEM teams will live in the future of synthetic biology, where the cost and effort of obtaining the required DNA constructs are no longer limiting factors. Thanks to IDT, the teams can focus on imagining, engineering, and testing the novel devices they create to solve important world problems. This is the promise of DNA synthesis and the future of the industry.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
E-cigarette users experience similar DNA changes to specific cheek cells as smokers